US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Oct 13, 2022 (4 years ago)

Ketorolac Tromethamine Ophthalmic Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations:

What was recalled

Ketorolac Tromethamine Ophthalmic Solution, 0.5%, Packaged as a) 10 mL dropper bottle, NDC 17478-209-11; (b) 3 mL dropper bottle, NDC 17478-209-19; (c) 5 mL dropper bottle, NDC 17478-209-10; Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.

Recalling firm
Akorn, Inc.
NDC code
17478-209-11
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0141-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ketorolac recalls

See all
Class II · Moderate risk Ongoing

Dexamethasone Moxifloxacin Ketorolac

Reason Presence of particulate matter - Glass like particles.

Imprimis NJOF, LLC NDC 71384-513-01 D-0250-2026
Class II · Moderate risk Ongoing

R.E.C.K.

Reason Presence of Particulate Matter

QuVa Pharma, Inc. NDC 70092-1433-50 D-0113-2026
Class II · Moderate risk Ongoing

Ketorolac Tromethamine Injection

Reason Presence of Particulate Matter: Particulate matter identified as glass

Aspiro Pharma Limited NDC 31722-307-25 D-0036-2026
Class II · Moderate risk Ongoing

Ketorolac Tromethamine Ophthalmic Solution

Reason Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns

Apotex Corp. NDC 60505-1003-1 D-0677-2025